Xact Kapitalforvaltning’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
$13.5M Sell
56,640
-7,343
-11% -$1.75M 0.29% 69
2019
Q4
$14M Buy
63,983
+204
+0.3% +$44.7K 0.24% 82
2019
Q3
$10.8M Buy
63,779
+5,327
+9% +$902K 0.21% 94
2019
Q2
$10.7M Buy
58,452
+2,910
+5% +$534K 0.22% 89
2019
Q1
$10.2M Buy
55,542
+10,340
+23% +$1.9M 0.23% 81
2018
Q4
$7.49M Buy
45,202
+648
+1% +$107K 0.19% 96
2018
Q3
$8.59M Sell
44,554
-3,269
-7% -$630K 0.18% 108
2018
Q2
$8.13M Buy
47,823
+1,393
+3% +$237K 0.17% 119
2018
Q1
$7.57M Buy
46,430
+2,235
+5% +$364K 0.17% 119
2017
Q4
$6.62M Buy
44,195
+5,882
+15% +$881K 0.16% 135
2017
Q3
$5.83M Buy
38,313
+2,464
+7% +$375K 0.17% 141
2017
Q2
$4.62M Buy
35,849
+126
+0.4% +$16.2K 0.14% 167
2017
Q1
$3.91M Buy
35,723
+821
+2% +$89.8K 0.12% 199
2016
Q4
$2.57M Buy
34,902
+2,752
+9% +$203K 0.09% 253
2016
Q3
$2.8M Buy
+32,150
New +$2.8M 0.1% 237